Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verapamil Injection for Peyronie's Disease
jRCT1051250243Not yet recruiting
- Sponsor
- Osaka Umeda Shinshi Clinic
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of verapamil in Peyronie's disease, sponsored by Osaka Umeda Shinshi Clinic. Primary endpoint: Degree of penile curvature. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
verapamil
03
Conditions
Peyronie's disease
Beyond the preview
Go deeper on jRCT1051250243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051250243.